Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Dimitrios, Karamanolakis"'
Publikováno v:
Clinical Cancer Drugs. 3:16-22
Autor:
Victoria Gennimata, Alkiviades Grigorakis, Dimitrios Karamanolakis, Natalia G. Vallianou, Fotis Constantinou
Publikováno v:
The American journal of emergency medicine. 36(10)
Urinothorax was first described in 1968 by Corriere et al. as the presence of urine in the pleural cavity due to retroperitoneal leakage of accumulated urine. Herein, we present a female patient, who complained of dyspnea due to urinothorax. This is
Autor:
Dimitrios Karamanolakis, Ashoke Roy, Amrit Rao, Manit Arya, Paul Rouse, Philippe Grange, Chryssanthos Kouriefs
Publikováno v:
BJU International. 109:808-817
Publikováno v:
Therapy. 7:423-427
Background & purpose: Flexible ureterorenoscopes (fURSs) have become an essential tool in endourological practice. In 2006, a new generation of digital fURSs (Invisio® DUR-D, ACMI, USA) with new optical technology was introduced. We have compared bo
Autor:
Nea Pitulis, Theodoros Dimopoulos, Haralampos Katopodis, Dimitrios Karamanolakis, Michael Koutsilieris, Antonis Halapas, John Bogdanos, N Pissimissis, Effie Papageorgiou, Peter Dimopoulos, Antigone Sourla, Constantine Milathianakis, Peter Lembessis, Roxane Tenta
Publikováno v:
Expert Opinion on Investigational Drugs. 15:795-804
The development of resistance to anticancer therapies is a major hurdle in preventing long-lasting clinical responses to conventional therapies in hormone-refractory prostate cancer. Herein, the molecular evidence documenting that bone metastasis mic
Autor:
Constantine S. Mitsiades, Dimitrios Karamanolakis, Athanassios Tsintavis, Roxane Tenta, Constantine Milathianakis, Michael Koutsilieris, John Bogdanos
Publikováno v:
Endocrine-related cancer. :279-289
Bone is the most frequent site of metastases of prostate cancer and is almost always the first and frequently the only site of metastases where disease will progress to stage D3. In addition, the number of skeletal metastatic foci is the most powerfu
Autor:
Dimitrios Karamanolakis
Μελετήσαμε αν η τεστοστερόνη ορού θα μπορούσε να γίνει μία συμπληρωματική δοκιμασία για να δοκιμάσουμε εάν ο κίνδυνος για διάγνωση του
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43024ddff3700e8d1dd638d96de3a32d
https://doi.org/10.12681/eadd/24345
https://doi.org/10.12681/eadd/24345
Autor:
Antonis Halapas, Dimitrios Karamanolakis, Andreas Papaioannou, Nicholas Pissimissis, Theodore Dimopoulos, Antigone Sourla, Peter Lembessis, John Bogdanos, Constantine Milathianakis, Michael Koutsilieris
Publikováno v:
BJU International. 100:60-62
Michael Koutsilieris, Theodore Dimopoulos*, Constantine Milathianakis†, John Bogdanos, Dimitrios Karamanolakis, Nicholas Pissimissis, Antonis Halapas, Peter Lembessis, Andreas Papaioannou‡ and Antigone Sourla¶ Department of Experimental Physiolo
Publikováno v:
International Journal of Urology. 12:776-778
Background: Inguinal lymphadenectomy has an essential role in the cure of patients with inguinal metastasis from penile cancer; however, this procedure is associated with a significant morbidity. In recent years, modified lymphadenectomy with sapheno
Autor:
Philippe, Grange, Paul, Rouse, Chryssanthos, Kouriefs, Amrit, Rao, Dimitrios, Karamanolakis, Ashoke, Roy, Manit, Arya
Publikováno v:
BJU international. 109(5)